lanzhou foci pharmaceutica-a
(002644:Shenzhen)

Last CNY22.34 CNY

Change Today +0.06 / 0.27%

Volume 1.5M

002644 On Other Exchanges

Symbol

Exchange

002644:CH

Shenzhen

As of 11:30 PM 05/19/13 All times are local (Market data is delayed by at least 15 minutes).

lanzhou foci pharmaceutica-a (002644) Snapshot

Open CNY22.29		Previous Close CNY22.28
Day High CNY23.25		Day Low CNY21.81
52 Week High 03/28/13 - CNY25.97		52 Week Low 05/28/12 - CNY13.39
Market Cap 2.0B		Average Volume 10 Days 1.0M
EPS TTM CNY0.34		Shares Outstanding 88.9M
EX-Date --		P/E TM 65.7x
Dividend CNY0.03		Dividend Yield 0.15%

Current Stock Chart for LANZHOU FOCI PHARMACEUTICA-A (002644)

002644:CH Historical Stock Quote
002644:CH Advanced Stock Chart

Related News

No related news articles were found.

lanzhou foci pharmaceutica-a (002644) Related Businessweek News

No Related Businessweek News Found

lanzhou foci pharmaceutica-a (002644) Details

Lanzhou Foci Pharmaceutical Co., Ltd. manufacturers and distributes traditional Chinese medicines primarily in China. The company offers its products in the forms of pills, tablets, capsules, granules, etc. under the Min Shan and Foci brand names. Lanzhou Foci Pharmaceutical Co., Ltd. also exports its products to approximately 27 countries and areas, such as the United States, the United Kingdom, Canada, Japan, Singapore, Indonesia, Thailand, Malaysia, the Netherlands, New Zealand, Australia, Russia, Ukraine, and Hong Kong. The company was founded in 1929 and is based in Lanzhou, China.

Detailed 002644:CH Company Description...

www.fczy.com

Founded in 1929

lanzhou foci pharmaceutica-a (002644) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

lanzhou foci pharmaceutica-a (002644) Key Developments

Lanzhou Foci Pharmaceutical Co.,Ltd. to Report Q1, 2013 Results on Apr 20, 2013

Apr 19 13

Lanzhou Foci Pharmaceutical Co.,Ltd. announced that they will report Q1, 2013 results on Apr 20, 2013

Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year 2012

Apr 11 13

Lanzhou Foci Pharmaceutical Co.,Ltd. proposed final cash dividend of CNY 0.31000000 per 10 shares (tax included) for 2012.

Lanzhou Foci Pharmaceutical Co.,Ltd., Annual General Meeting, May 07, 2013

Apr 11 13

Lanzhou Foci Pharmaceutical Co.,Ltd., Annual General Meeting, May 07, 2013., at 09:00 China Standard Time. Agenda: To consider 2012 work report of the board of directors; to consider 2012 work report of the supervisory committee; to consider 2012 annual report and its summary; to consider 2012 internal control self-evaluation report; to consider 2012 financial resolution report; to consider 2012 profit distribution plan; to consider special report on storage and use of raised funds in 2012; to consider special report on fund embezzlement by controlling shareholders and related parties in 2012; and to consider appointment of audit firm.